Staphylococcus aureus Pneumonia: Preceding Influenza Infection Paves the Way for Low-Virulent Strains.
Stefanie Deinhardt-EmmerKaroline Frieda HauptMarina Garcia-MorenoJennifer GeraciChristina ForstnerMathias W PletzChristina EhrhardtBettina LöfflerPublished in: Toxins (2019)
Staphylococcus aureus is a facultative pathogenic bacterium that colonizes the nasopharyngeal area of healthy individuals, but can also induce severe infection, such as pneumonia. Pneumonia caused by mono- or superinfected S. aureus leads to high mortality rates. To establish an infection, S. aureus disposes of a wide variety of virulence factors, which can vary between clinical isolates. Our study aimed to characterize pneumonia isolates for their virulent capacity. For this, we analyzed isolates from colonization, pneumonia due to S. aureus, and pneumonia due to S. aureus/influenza virus co-infection. A total of 70 strains were analyzed for their virulence genes and the host-pathogen interaction was analyzed through functional assays in cell culture systems. Strains from pneumonia due to S. aureus mono-infection showed enhanced invasion and cytotoxicity against professional phagocytes than colonizing and co-infecting strains. This corresponded to the high presence of cytotoxic components in pneumonia strains. By contrast, strains obtained from co-infection did not exhibit these virulence characteristics and resembled strains from colonization, although they caused the highest mortality rate in patients. Taken together, our results underline the requirement of invasion and toxins to cause pneumonia due to S. aureus mono-infection, whereas in co-infection even low-virulent strains can severely aggravate pneumonia.
Keyphrases
- escherichia coli
- staphylococcus aureus
- respiratory failure
- biofilm formation
- community acquired pneumonia
- pseudomonas aeruginosa
- antimicrobial resistance
- computed tomography
- magnetic resonance imaging
- dna methylation
- prognostic factors
- ejection fraction
- transcription factor
- chronic kidney disease
- coronary artery disease
- candida albicans
- anti inflammatory
- drug induced